Compare PRAX & SBSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | SBSW |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | South Africa |
| Employees | N/A | 72668 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 5.9B |
| IPO Year | 2020 | N/A |
| Metric | PRAX | SBSW |
|---|---|---|
| Price | $322.54 | $8.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 3 |
| Target Price | ★ $572.13 | $19.93 |
| AVG Volume (30 Days) | 548.0K | ★ 5.5M |
| Earning Date | 05-08-2026 | 02-20-2026 |
| Dividend Yield | N/A | ★ 2.17% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $43.55 |
| Revenue Next Year | $7,758.26 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $37.25 | $7.10 |
| 52 Week High | $366.52 | $21.29 |
| Indicator | PRAX | SBSW |
|---|---|---|
| Relative Strength Index (RSI) | 54.07 | 37.88 |
| Support Level | $282.49 | N/A |
| Resistance Level | $344.07 | $11.25 |
| Average True Range (ATR) | 21.29 | 0.31 |
| MACD | 2.92 | 0.06 |
| Stochastic Oscillator | 54.65 | 40.21 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other. Group operations are divided into two segments, South African Operations and International and recycling operations.